article thumbnail

Pharmaceutical Continuous Manufacturing: Regulatory landscape in the spotlight at USP workshop

Quality Matters

FDA representatives emphasized the agency’s commitment to working with industry to mitigate potential regulatory hurdles to PCM adoption during USP’s workshop on “ Identifying and Addressing Barriers to Continuous Manufacturing Adoption ” July 18-19 in Rockville, Maryland. It is not intended as a comprehensive summary or report.

article thumbnail

Event Summary – Masterclass: International Pharma Marketing by Shailesh Kapadia

PharmaState Academy

The workshop, led by Educator Shailesh KAPADIA, CCPE® , prompted insightful discussions on career-related aspects within the field. He highlighted potential opportunities due to the low cost of skilled labor, expanding market size, and increasing global demand for generic drugs.

article thumbnail

Q&A: Building a More Resilient Medicines Supply Chain

Quality Matters

Through its standards, scientific expertise, capability building solutions, unique insights, and work with organizations like Duke-Margolis, USP is working to enable a more resilient medicine supply chain so that people can get their medicines when they need them.